MARTIN MACKAY

CIK 1414815 · Executive Chairman · last filed 2026-05-11

MARTIN MACKAY is an Executive Chairman who has filed 89 SEC Form 4 insider transactions across 6 companies since 2007. The most recent filing shows the insider was granted $505.3K of CRL on May 11, 2026. Across all open-market trades the lifetime net is +$103.5K, making them a net buyer over the disclosed history. Current disclosed insider exposure totals $24.5M across reported positions.

"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.

Loading insider history…
Disclosed Exposure

$24.53M

Companies

6

Total Filings

89

Lifetime Open-Market Net

$103.5K

Holdings By Company

Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
Symbol Role Shares Price Disclosed Exposure Lifetime OM Net Filings Latest Filed
CRL Director 15,730 $187.51 $2.95M $0 13 2026-05-11
KLRA Director $0 1 2026-04-20
RLYB Executive Chairman 714,630 $15.92 $11.38M $103.5K 7 2026-02-20
SpringWorks Therapeutics, Inc. (SWTX) Delisted Director 0 $46.99 $0 $0 3 2025-07-02
5:01 Acquisition Corp. (FVAM) Delisted Director $10.00 $0 1 2020-10-20
PFE Senior Vice President 389,172 $26.21 $10.20M $0 50 2010-05-18

Recent Filings

89 filings
Form 4 transactions across all companies, newest first.
Filed Symbol Action Net Shares Net $ Link
2026-05-11 CRL Grant (A) +2,845 $505.3K EDGAR
2026-04-20 KLRA Grant (A) $0 EDGAR
2026-02-20 RLYB Grant (A) $0 EDGAR
2025-07-02 SpringWorks Therapeutics, Inc. (SWTX) Delisted Disp (D) −20,023 $0 EDGAR
2025-05-23 CRL Grant (A) +1,761 $237.7K EDGAR
2025-05-15 RLYB Grant (A) $0 EDGAR
2025-05-15 SpringWorks Therapeutics, Inc. (SWTX) Delisted Grant (A) +10,060 $0 EDGAR
2025-01-06 RLYB Grant (A) $0 EDGAR
2024-07-30 SpringWorks Therapeutics, Inc. (SWTX) Delisted Grant (A) +9,963 $0 EDGAR
2024-05-15 CRL Grant (A) +931 $212.6K EDGAR
Showing 110 of 89
Page 1 of 9
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.